Stockreport

Correction Notice of Palisade Bio’s Press Release Announcing the Appointment of Clinical Advisory Board Members

Palisade Bio, Inc.  (PALI) 
PDF Carlsbad, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc.  (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on developing nov [Read more]